Global Rabies Immune Globulin (Human) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Rabies Immune Globulin (Human) market size was valued at USD 1543.4 million in 2022 and is forecast to a readjusted size of USD 2007.6 million by 2029 with a CAGR of 3.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The market for Rabies Immune Globulin (Human) is primarily driven by the incidence of rabies in different regions of the world. According to the World Health Organization, rabies is present in more than 150 countries, with an estimated 59,000 human deaths annually. The majority of these deaths occur in Asia and Africa, where access to post-exposure prophylaxis may be limited.
In addition, the market for Rabies Immune Globulin (Human) is also influenced by government policies and regulations related to rabies prevention and control. Many countries have established national vaccination programs and guidelines for post-exposure prophylaxis, which may include the use of Rabies Immune Globulin (Human).
Overall, the market for Rabies Immune Globulin (Human) is expected to continue to grow as awareness of rabies and the importance of post-exposure prophylaxis increases, particularly in regions with high incidence of the disease.
This report is a detailed and comprehensive analysis for global Rabies Immune Globulin (Human) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Rabies Immune Globulin (Human) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rabies Immune Globulin (Human) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rabies Immune Globulin (Human) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rabies Immune Globulin (Human) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rabies Immune Globulin (Human)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rabies Immune Globulin (Human) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Grifols, Sanofi, Kamada and Bharat Serum, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Rabies Immune Globulin (Human) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Rabies Immune Globulin (Human) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rabies Immune Globulin (Human), with price, sales, revenue and global market share of Rabies Immune Globulin (Human) from 2018 to 2023.
Chapter 3, the Rabies Immune Globulin (Human) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rabies Immune Globulin (Human) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Rabies Immune Globulin (Human) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rabies Immune Globulin (Human).
Chapter 14 and 15, to describe Rabies Immune Globulin (Human) sales channel, distributors, customers, research findings and conclusion.
The market for Rabies Immune Globulin (Human) is primarily driven by the incidence of rabies in different regions of the world. According to the World Health Organization, rabies is present in more than 150 countries, with an estimated 59,000 human deaths annually. The majority of these deaths occur in Asia and Africa, where access to post-exposure prophylaxis may be limited.
In addition, the market for Rabies Immune Globulin (Human) is also influenced by government policies and regulations related to rabies prevention and control. Many countries have established national vaccination programs and guidelines for post-exposure prophylaxis, which may include the use of Rabies Immune Globulin (Human).
Overall, the market for Rabies Immune Globulin (Human) is expected to continue to grow as awareness of rabies and the importance of post-exposure prophylaxis increases, particularly in regions with high incidence of the disease.
This report is a detailed and comprehensive analysis for global Rabies Immune Globulin (Human) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Rabies Immune Globulin (Human) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rabies Immune Globulin (Human) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rabies Immune Globulin (Human) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rabies Immune Globulin (Human) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rabies Immune Globulin (Human)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rabies Immune Globulin (Human) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Grifols, Sanofi, Kamada and Bharat Serum, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Rabies Immune Globulin (Human) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- HyperRAB S/D
- KEDRAB
- Clinic
- Hospital
- CSL Behring
- Grifols
- Sanofi
- Kamada
- Bharat Serum
- Bio Products Laboratory
- Shanghai RAAS
- Weiguang Bio
- Shuanglin Bio
- CBPO
- CNBG
- Sichuan Yuanda Shuyang
- Kedrion Biopharma
- Congruent Pharmachem
- hualanbio
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Rabies Immune Globulin (Human) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rabies Immune Globulin (Human), with price, sales, revenue and global market share of Rabies Immune Globulin (Human) from 2018 to 2023.
Chapter 3, the Rabies Immune Globulin (Human) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rabies Immune Globulin (Human) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Rabies Immune Globulin (Human) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rabies Immune Globulin (Human).
Chapter 14 and 15, to describe Rabies Immune Globulin (Human) sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Rabies Immune Globulin (Human)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rabies Immune Globulin (Human) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 HyperRAB S/D
1.3.3 KEDRAB
1.4 Market Analysis by Application
1.4.1 Overview: Global Rabies Immune Globulin (Human) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Clinic
1.4.3 Hospital
1.5 Global Rabies Immune Globulin (Human) Market Size & Forecast
1.5.1 Global Rabies Immune Globulin (Human) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Rabies Immune Globulin (Human) Sales Quantity (2018-2029)
1.5.3 Global Rabies Immune Globulin (Human) Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business
2.1.3 CSL Behring Rabies Immune Globulin (Human) Product and Services
2.1.4 CSL Behring Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CSL Behring Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Rabies Immune Globulin (Human) Product and Services
2.2.4 Grifols Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Grifols Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Rabies Immune Globulin (Human) Product and Services
2.3.4 Sanofi Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 Kamada
2.4.1 Kamada Details
2.4.2 Kamada Major Business
2.4.3 Kamada Rabies Immune Globulin (Human) Product and Services
2.4.4 Kamada Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Kamada Recent Developments/Updates
2.5 Bharat Serum
2.5.1 Bharat Serum Details
2.5.2 Bharat Serum Major Business
2.5.3 Bharat Serum Rabies Immune Globulin (Human) Product and Services
2.5.4 Bharat Serum Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bharat Serum Recent Developments/Updates
2.6 Bio Products Laboratory
2.6.1 Bio Products Laboratory Details
2.6.2 Bio Products Laboratory Major Business
2.6.3 Bio Products Laboratory Rabies Immune Globulin (Human) Product and Services
2.6.4 Bio Products Laboratory Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bio Products Laboratory Recent Developments/Updates
2.7 Shanghai RAAS
2.7.1 Shanghai RAAS Details
2.7.2 Shanghai RAAS Major Business
2.7.3 Shanghai RAAS Rabies Immune Globulin (Human) Product and Services
2.7.4 Shanghai RAAS Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Shanghai RAAS Recent Developments/Updates
2.8 Weiguang Bio
2.8.1 Weiguang Bio Details
2.8.2 Weiguang Bio Major Business
2.8.3 Weiguang Bio Rabies Immune Globulin (Human) Product and Services
2.8.4 Weiguang Bio Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Weiguang Bio Recent Developments/Updates
2.9 Shuanglin Bio
2.9.1 Shuanglin Bio Details
2.9.2 Shuanglin Bio Major Business
2.9.3 Shuanglin Bio Rabies Immune Globulin (Human) Product and Services
2.9.4 Shuanglin Bio Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Shuanglin Bio Recent Developments/Updates
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Rabies Immune Globulin (Human) Product and Services
2.10.4 CBPO Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 CBPO Recent Developments/Updates
2.11 CNBG
2.11.1 CNBG Details
2.11.2 CNBG Major Business
2.11.3 CNBG Rabies Immune Globulin (Human) Product and Services
2.11.4 CNBG Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CNBG Recent Developments/Updates
2.12 Sichuan Yuanda Shuyang
2.12.1 Sichuan Yuanda Shuyang Details
2.12.2 Sichuan Yuanda Shuyang Major Business
2.12.3 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product and Services
2.12.4 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sichuan Yuanda Shuyang Recent Developments/Updates
2.13 Kedrion Biopharma
2.13.1 Kedrion Biopharma Details
2.13.2 Kedrion Biopharma Major Business
2.13.3 Kedrion Biopharma Rabies Immune Globulin (Human) Product and Services
2.13.4 Kedrion Biopharma Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Kedrion Biopharma Recent Developments/Updates
2.14 Congruent Pharmachem
2.14.1 Congruent Pharmachem Details
2.14.2 Congruent Pharmachem Major Business
2.14.3 Congruent Pharmachem Rabies Immune Globulin (Human) Product and Services
2.14.4 Congruent Pharmachem Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Congruent Pharmachem Recent Developments/Updates
2.15 hualanbio
2.15.1 hualanbio Details
2.15.2 hualanbio Major Business
2.15.3 hualanbio Rabies Immune Globulin (Human) Product and Services
2.15.4 hualanbio Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 hualanbio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RABIES IMMUNE GLOBULIN (HUMAN) BY MANUFACTURER
3.1 Global Rabies Immune Globulin (Human) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Rabies Immune Globulin (Human) Revenue by Manufacturer (2018-2023)
3.3 Global Rabies Immune Globulin (Human) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Rabies Immune Globulin (Human) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Rabies Immune Globulin (Human) Manufacturer Market Share in 2022
3.4.2 Top 6 Rabies Immune Globulin (Human) Manufacturer Market Share in 2022
3.5 Rabies Immune Globulin (Human) Market: Overall Company Footprint Analysis
3.5.1 Rabies Immune Globulin (Human) Market: Region Footprint
3.5.2 Rabies Immune Globulin (Human) Market: Company Product Type Footprint
3.5.3 Rabies Immune Globulin (Human) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Rabies Immune Globulin (Human) Market Size by Region
4.1.1 Global Rabies Immune Globulin (Human) Sales Quantity by Region (2018-2029)
4.1.2 Global Rabies Immune Globulin (Human) Consumption Value by Region (2018-2029)
4.1.3 Global Rabies Immune Globulin (Human) Average Price by Region (2018-2029)
4.2 North America Rabies Immune Globulin (Human) Consumption Value (2018-2029)
4.3 Europe Rabies Immune Globulin (Human) Consumption Value (2018-2029)
4.4 Asia-Pacific Rabies Immune Globulin (Human) Consumption Value (2018-2029)
4.5 South America Rabies Immune Globulin (Human) Consumption Value (2018-2029)
4.6 Middle East and Africa Rabies Immune Globulin (Human) Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2029)
5.2 Global Rabies Immune Globulin (Human) Consumption Value by Type (2018-2029)
5.3 Global Rabies Immune Globulin (Human) Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2029)
6.2 Global Rabies Immune Globulin (Human) Consumption Value by Application (2018-2029)
6.3 Global Rabies Immune Globulin (Human) Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2029)
7.2 North America Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2029)
7.3 North America Rabies Immune Globulin (Human) Market Size by Country
7.3.1 North America Rabies Immune Globulin (Human) Sales Quantity by Country (2018-2029)
7.3.2 North America Rabies Immune Globulin (Human) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2029)
8.2 Europe Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2029)
8.3 Europe Rabies Immune Globulin (Human) Market Size by Country
8.3.1 Europe Rabies Immune Globulin (Human) Sales Quantity by Country (2018-2029)
8.3.2 Europe Rabies Immune Globulin (Human) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Rabies Immune Globulin (Human) Market Size by Region
9.3.1 Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Rabies Immune Globulin (Human) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2029)
10.2 South America Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2029)
10.3 South America Rabies Immune Globulin (Human) Market Size by Country
10.3.1 South America Rabies Immune Globulin (Human) Sales Quantity by Country (2018-2029)
10.3.2 South America Rabies Immune Globulin (Human) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Rabies Immune Globulin (Human) Market Size by Country
11.3.1 Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Rabies Immune Globulin (Human) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Rabies Immune Globulin (Human) Market Drivers
12.2 Rabies Immune Globulin (Human) Market Restraints
12.3 Rabies Immune Globulin (Human) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Rabies Immune Globulin (Human) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rabies Immune Globulin (Human)
13.3 Rabies Immune Globulin (Human) Production Process
13.4 Rabies Immune Globulin (Human) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rabies Immune Globulin (Human) Typical Distributors
14.3 Rabies Immune Globulin (Human) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Rabies Immune Globulin (Human)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rabies Immune Globulin (Human) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 HyperRAB S/D
1.3.3 KEDRAB
1.4 Market Analysis by Application
1.4.1 Overview: Global Rabies Immune Globulin (Human) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Clinic
1.4.3 Hospital
1.5 Global Rabies Immune Globulin (Human) Market Size & Forecast
1.5.1 Global Rabies Immune Globulin (Human) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Rabies Immune Globulin (Human) Sales Quantity (2018-2029)
1.5.3 Global Rabies Immune Globulin (Human) Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business
2.1.3 CSL Behring Rabies Immune Globulin (Human) Product and Services
2.1.4 CSL Behring Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CSL Behring Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Rabies Immune Globulin (Human) Product and Services
2.2.4 Grifols Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Grifols Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Rabies Immune Globulin (Human) Product and Services
2.3.4 Sanofi Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 Kamada
2.4.1 Kamada Details
2.4.2 Kamada Major Business
2.4.3 Kamada Rabies Immune Globulin (Human) Product and Services
2.4.4 Kamada Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Kamada Recent Developments/Updates
2.5 Bharat Serum
2.5.1 Bharat Serum Details
2.5.2 Bharat Serum Major Business
2.5.3 Bharat Serum Rabies Immune Globulin (Human) Product and Services
2.5.4 Bharat Serum Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bharat Serum Recent Developments/Updates
2.6 Bio Products Laboratory
2.6.1 Bio Products Laboratory Details
2.6.2 Bio Products Laboratory Major Business
2.6.3 Bio Products Laboratory Rabies Immune Globulin (Human) Product and Services
2.6.4 Bio Products Laboratory Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bio Products Laboratory Recent Developments/Updates
2.7 Shanghai RAAS
2.7.1 Shanghai RAAS Details
2.7.2 Shanghai RAAS Major Business
2.7.3 Shanghai RAAS Rabies Immune Globulin (Human) Product and Services
2.7.4 Shanghai RAAS Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Shanghai RAAS Recent Developments/Updates
2.8 Weiguang Bio
2.8.1 Weiguang Bio Details
2.8.2 Weiguang Bio Major Business
2.8.3 Weiguang Bio Rabies Immune Globulin (Human) Product and Services
2.8.4 Weiguang Bio Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Weiguang Bio Recent Developments/Updates
2.9 Shuanglin Bio
2.9.1 Shuanglin Bio Details
2.9.2 Shuanglin Bio Major Business
2.9.3 Shuanglin Bio Rabies Immune Globulin (Human) Product and Services
2.9.4 Shuanglin Bio Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Shuanglin Bio Recent Developments/Updates
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Rabies Immune Globulin (Human) Product and Services
2.10.4 CBPO Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 CBPO Recent Developments/Updates
2.11 CNBG
2.11.1 CNBG Details
2.11.2 CNBG Major Business
2.11.3 CNBG Rabies Immune Globulin (Human) Product and Services
2.11.4 CNBG Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CNBG Recent Developments/Updates
2.12 Sichuan Yuanda Shuyang
2.12.1 Sichuan Yuanda Shuyang Details
2.12.2 Sichuan Yuanda Shuyang Major Business
2.12.3 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product and Services
2.12.4 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sichuan Yuanda Shuyang Recent Developments/Updates
2.13 Kedrion Biopharma
2.13.1 Kedrion Biopharma Details
2.13.2 Kedrion Biopharma Major Business
2.13.3 Kedrion Biopharma Rabies Immune Globulin (Human) Product and Services
2.13.4 Kedrion Biopharma Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Kedrion Biopharma Recent Developments/Updates
2.14 Congruent Pharmachem
2.14.1 Congruent Pharmachem Details
2.14.2 Congruent Pharmachem Major Business
2.14.3 Congruent Pharmachem Rabies Immune Globulin (Human) Product and Services
2.14.4 Congruent Pharmachem Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Congruent Pharmachem Recent Developments/Updates
2.15 hualanbio
2.15.1 hualanbio Details
2.15.2 hualanbio Major Business
2.15.3 hualanbio Rabies Immune Globulin (Human) Product and Services
2.15.4 hualanbio Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 hualanbio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RABIES IMMUNE GLOBULIN (HUMAN) BY MANUFACTURER
3.1 Global Rabies Immune Globulin (Human) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Rabies Immune Globulin (Human) Revenue by Manufacturer (2018-2023)
3.3 Global Rabies Immune Globulin (Human) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Rabies Immune Globulin (Human) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Rabies Immune Globulin (Human) Manufacturer Market Share in 2022
3.4.2 Top 6 Rabies Immune Globulin (Human) Manufacturer Market Share in 2022
3.5 Rabies Immune Globulin (Human) Market: Overall Company Footprint Analysis
3.5.1 Rabies Immune Globulin (Human) Market: Region Footprint
3.5.2 Rabies Immune Globulin (Human) Market: Company Product Type Footprint
3.5.3 Rabies Immune Globulin (Human) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Rabies Immune Globulin (Human) Market Size by Region
4.1.1 Global Rabies Immune Globulin (Human) Sales Quantity by Region (2018-2029)
4.1.2 Global Rabies Immune Globulin (Human) Consumption Value by Region (2018-2029)
4.1.3 Global Rabies Immune Globulin (Human) Average Price by Region (2018-2029)
4.2 North America Rabies Immune Globulin (Human) Consumption Value (2018-2029)
4.3 Europe Rabies Immune Globulin (Human) Consumption Value (2018-2029)
4.4 Asia-Pacific Rabies Immune Globulin (Human) Consumption Value (2018-2029)
4.5 South America Rabies Immune Globulin (Human) Consumption Value (2018-2029)
4.6 Middle East and Africa Rabies Immune Globulin (Human) Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2029)
5.2 Global Rabies Immune Globulin (Human) Consumption Value by Type (2018-2029)
5.3 Global Rabies Immune Globulin (Human) Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2029)
6.2 Global Rabies Immune Globulin (Human) Consumption Value by Application (2018-2029)
6.3 Global Rabies Immune Globulin (Human) Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2029)
7.2 North America Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2029)
7.3 North America Rabies Immune Globulin (Human) Market Size by Country
7.3.1 North America Rabies Immune Globulin (Human) Sales Quantity by Country (2018-2029)
7.3.2 North America Rabies Immune Globulin (Human) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2029)
8.2 Europe Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2029)
8.3 Europe Rabies Immune Globulin (Human) Market Size by Country
8.3.1 Europe Rabies Immune Globulin (Human) Sales Quantity by Country (2018-2029)
8.3.2 Europe Rabies Immune Globulin (Human) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Rabies Immune Globulin (Human) Market Size by Region
9.3.1 Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Rabies Immune Globulin (Human) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2029)
10.2 South America Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2029)
10.3 South America Rabies Immune Globulin (Human) Market Size by Country
10.3.1 South America Rabies Immune Globulin (Human) Sales Quantity by Country (2018-2029)
10.3.2 South America Rabies Immune Globulin (Human) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Rabies Immune Globulin (Human) Market Size by Country
11.3.1 Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Rabies Immune Globulin (Human) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Rabies Immune Globulin (Human) Market Drivers
12.2 Rabies Immune Globulin (Human) Market Restraints
12.3 Rabies Immune Globulin (Human) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Rabies Immune Globulin (Human) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rabies Immune Globulin (Human)
13.3 Rabies Immune Globulin (Human) Production Process
13.4 Rabies Immune Globulin (Human) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rabies Immune Globulin (Human) Typical Distributors
14.3 Rabies Immune Globulin (Human) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Rabies Immune Globulin (Human) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Rabies Immune Globulin (Human) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 4. CSL Behring Major Business
Table 5. CSL Behring Rabies Immune Globulin (Human) Product and Services
Table 6. CSL Behring Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. CSL Behring Recent Developments/Updates
Table 8. Grifols Basic Information, Manufacturing Base and Competitors
Table 9. Grifols Major Business
Table 10. Grifols Rabies Immune Globulin (Human) Product and Services
Table 11. Grifols Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Grifols Recent Developments/Updates
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Major Business
Table 15. Sanofi Rabies Immune Globulin (Human) Product and Services
Table 16. Sanofi Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi Recent Developments/Updates
Table 18. Kamada Basic Information, Manufacturing Base and Competitors
Table 19. Kamada Major Business
Table 20. Kamada Rabies Immune Globulin (Human) Product and Services
Table 21. Kamada Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Kamada Recent Developments/Updates
Table 23. Bharat Serum Basic Information, Manufacturing Base and Competitors
Table 24. Bharat Serum Major Business
Table 25. Bharat Serum Rabies Immune Globulin (Human) Product and Services
Table 26. Bharat Serum Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Bharat Serum Recent Developments/Updates
Table 28. Bio Products Laboratory Basic Information, Manufacturing Base and Competitors
Table 29. Bio Products Laboratory Major Business
Table 30. Bio Products Laboratory Rabies Immune Globulin (Human) Product and Services
Table 31. Bio Products Laboratory Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bio Products Laboratory Recent Developments/Updates
Table 33. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 34. Shanghai RAAS Major Business
Table 35. Shanghai RAAS Rabies Immune Globulin (Human) Product and Services
Table 36. Shanghai RAAS Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Shanghai RAAS Recent Developments/Updates
Table 38. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 39. Weiguang Bio Major Business
Table 40. Weiguang Bio Rabies Immune Globulin (Human) Product and Services
Table 41. Weiguang Bio Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Weiguang Bio Recent Developments/Updates
Table 43. Shuanglin Bio Basic Information, Manufacturing Base and Competitors
Table 44. Shuanglin Bio Major Business
Table 45. Shuanglin Bio Rabies Immune Globulin (Human) Product and Services
Table 46. Shuanglin Bio Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Shuanglin Bio Recent Developments/Updates
Table 48. CBPO Basic Information, Manufacturing Base and Competitors
Table 49. CBPO Major Business
Table 50. CBPO Rabies Immune Globulin (Human) Product and Services
Table 51. CBPO Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. CBPO Recent Developments/Updates
Table 53. CNBG Basic Information, Manufacturing Base and Competitors
Table 54. CNBG Major Business
Table 55. CNBG Rabies Immune Globulin (Human) Product and Services
Table 56. CNBG Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. CNBG Recent Developments/Updates
Table 58. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 59. Sichuan Yuanda Shuyang Major Business
Table 60. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product and Services
Table 61. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 63. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 64. Kedrion Biopharma Major Business
Table 65. Kedrion Biopharma Rabies Immune Globulin (Human) Product and Services
Table 66. Kedrion Biopharma Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Kedrion Biopharma Recent Developments/Updates
Table 68. Congruent Pharmachem Basic Information, Manufacturing Base and Competitors
Table 69. Congruent Pharmachem Major Business
Table 70. Congruent Pharmachem Rabies Immune Globulin (Human) Product and Services
Table 71. Congruent Pharmachem Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Congruent Pharmachem Recent Developments/Updates
Table 73. hualanbio Basic Information, Manufacturing Base and Competitors
Table 74. hualanbio Major Business
Table 75. hualanbio Rabies Immune Globulin (Human) Product and Services
Table 76. hualanbio Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. hualanbio Recent Developments/Updates
Table 78. Global Rabies Immune Globulin (Human) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Rabies Immune Globulin (Human) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Rabies Immune Globulin (Human) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Rabies Immune Globulin (Human), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Rabies Immune Globulin (Human) Production Site of Key Manufacturer
Table 83. Rabies Immune Globulin (Human) Market: Company Product Type Footprint
Table 84. Rabies Immune Globulin (Human) Market: Company Product Application Footprint
Table 85. Rabies Immune Globulin (Human) New Market Entrants and Barriers to Market Entry
Table 86. Rabies Immune Globulin (Human) Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Rabies Immune Globulin (Human) Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Rabies Immune Globulin (Human) Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Rabies Immune Globulin (Human) Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Rabies Immune Globulin (Human) Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Rabies Immune Globulin (Human) Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Rabies Immune Globulin (Human) Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Rabies Immune Globulin (Human) Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Rabies Immune Globulin (Human) Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Rabies Immune Globulin (Human) Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Rabies Immune Globulin (Human) Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Rabies Immune Globulin (Human) Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Rabies Immune Globulin (Human) Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Rabies Immune Globulin (Human) Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Rabies Immune Globulin (Human) Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Rabies Immune Globulin (Human) Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Rabies Immune Globulin (Human) Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Rabies Immune Globulin (Human) Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Rabies Immune Globulin (Human) Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Rabies Immune Globulin (Human) Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Rabies Immune Globulin (Human) Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Rabies Immune Globulin (Human) Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Rabies Immune Globulin (Human) Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Rabies Immune Globulin (Human) Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Rabies Immune Globulin (Human) Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Rabies Immune Globulin (Human) Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Rabies Immune Globulin (Human) Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Rabies Immune Globulin (Human) Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Rabies Immune Globulin (Human) Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Rabies Immune Globulin (Human) Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Rabies Immune Globulin (Human) Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Rabies Immune Globulin (Human) Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Rabies Immune Globulin (Human) Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Rabies Immune Globulin (Human) Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Rabies Immune Globulin (Human) Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Rabies Immune Globulin (Human) Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Rabies Immune Globulin (Human) Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Rabies Immune Globulin (Human) Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Rabies Immune Globulin (Human) Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Rabies Immune Globulin (Human) Raw Material
Table 146. Key Manufacturers of Rabies Immune Globulin (Human) Raw Materials
Table 147. Rabies Immune Globulin (Human) Typical Distributors
Table 148. Rabies Immune Globulin (Human) Typical Customers
Table 1. Global Rabies Immune Globulin (Human) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Rabies Immune Globulin (Human) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 4. CSL Behring Major Business
Table 5. CSL Behring Rabies Immune Globulin (Human) Product and Services
Table 6. CSL Behring Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. CSL Behring Recent Developments/Updates
Table 8. Grifols Basic Information, Manufacturing Base and Competitors
Table 9. Grifols Major Business
Table 10. Grifols Rabies Immune Globulin (Human) Product and Services
Table 11. Grifols Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Grifols Recent Developments/Updates
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Major Business
Table 15. Sanofi Rabies Immune Globulin (Human) Product and Services
Table 16. Sanofi Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi Recent Developments/Updates
Table 18. Kamada Basic Information, Manufacturing Base and Competitors
Table 19. Kamada Major Business
Table 20. Kamada Rabies Immune Globulin (Human) Product and Services
Table 21. Kamada Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Kamada Recent Developments/Updates
Table 23. Bharat Serum Basic Information, Manufacturing Base and Competitors
Table 24. Bharat Serum Major Business
Table 25. Bharat Serum Rabies Immune Globulin (Human) Product and Services
Table 26. Bharat Serum Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Bharat Serum Recent Developments/Updates
Table 28. Bio Products Laboratory Basic Information, Manufacturing Base and Competitors
Table 29. Bio Products Laboratory Major Business
Table 30. Bio Products Laboratory Rabies Immune Globulin (Human) Product and Services
Table 31. Bio Products Laboratory Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bio Products Laboratory Recent Developments/Updates
Table 33. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 34. Shanghai RAAS Major Business
Table 35. Shanghai RAAS Rabies Immune Globulin (Human) Product and Services
Table 36. Shanghai RAAS Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Shanghai RAAS Recent Developments/Updates
Table 38. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 39. Weiguang Bio Major Business
Table 40. Weiguang Bio Rabies Immune Globulin (Human) Product and Services
Table 41. Weiguang Bio Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Weiguang Bio Recent Developments/Updates
Table 43. Shuanglin Bio Basic Information, Manufacturing Base and Competitors
Table 44. Shuanglin Bio Major Business
Table 45. Shuanglin Bio Rabies Immune Globulin (Human) Product and Services
Table 46. Shuanglin Bio Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Shuanglin Bio Recent Developments/Updates
Table 48. CBPO Basic Information, Manufacturing Base and Competitors
Table 49. CBPO Major Business
Table 50. CBPO Rabies Immune Globulin (Human) Product and Services
Table 51. CBPO Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. CBPO Recent Developments/Updates
Table 53. CNBG Basic Information, Manufacturing Base and Competitors
Table 54. CNBG Major Business
Table 55. CNBG Rabies Immune Globulin (Human) Product and Services
Table 56. CNBG Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. CNBG Recent Developments/Updates
Table 58. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 59. Sichuan Yuanda Shuyang Major Business
Table 60. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product and Services
Table 61. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 63. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 64. Kedrion Biopharma Major Business
Table 65. Kedrion Biopharma Rabies Immune Globulin (Human) Product and Services
Table 66. Kedrion Biopharma Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Kedrion Biopharma Recent Developments/Updates
Table 68. Congruent Pharmachem Basic Information, Manufacturing Base and Competitors
Table 69. Congruent Pharmachem Major Business
Table 70. Congruent Pharmachem Rabies Immune Globulin (Human) Product and Services
Table 71. Congruent Pharmachem Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Congruent Pharmachem Recent Developments/Updates
Table 73. hualanbio Basic Information, Manufacturing Base and Competitors
Table 74. hualanbio Major Business
Table 75. hualanbio Rabies Immune Globulin (Human) Product and Services
Table 76. hualanbio Rabies Immune Globulin (Human) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. hualanbio Recent Developments/Updates
Table 78. Global Rabies Immune Globulin (Human) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Rabies Immune Globulin (Human) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Rabies Immune Globulin (Human) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Rabies Immune Globulin (Human), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Rabies Immune Globulin (Human) Production Site of Key Manufacturer
Table 83. Rabies Immune Globulin (Human) Market: Company Product Type Footprint
Table 84. Rabies Immune Globulin (Human) Market: Company Product Application Footprint
Table 85. Rabies Immune Globulin (Human) New Market Entrants and Barriers to Market Entry
Table 86. Rabies Immune Globulin (Human) Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Rabies Immune Globulin (Human) Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Rabies Immune Globulin (Human) Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Rabies Immune Globulin (Human) Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Rabies Immune Globulin (Human) Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Rabies Immune Globulin (Human) Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Rabies Immune Globulin (Human) Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Rabies Immune Globulin (Human) Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Rabies Immune Globulin (Human) Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Rabies Immune Globulin (Human) Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Rabies Immune Globulin (Human) Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Rabies Immune Globulin (Human) Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Rabies Immune Globulin (Human) Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Rabies Immune Globulin (Human) Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Rabies Immune Globulin (Human) Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Rabies Immune Globulin (Human) Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Rabies Immune Globulin (Human) Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Rabies Immune Globulin (Human) Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Rabies Immune Globulin (Human) Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Rabies Immune Globulin (Human) Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Rabies Immune Globulin (Human) Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Rabies Immune Globulin (Human) Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Rabies Immune Globulin (Human) Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Rabies Immune Globulin (Human) Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Rabies Immune Globulin (Human) Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Rabies Immune Globulin (Human) Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Rabies Immune Globulin (Human) Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Rabies Immune Globulin (Human) Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Rabies Immune Globulin (Human) Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Rabies Immune Globulin (Human) Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Rabies Immune Globulin (Human) Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Rabies Immune Globulin (Human) Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Rabies Immune Globulin (Human) Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Rabies Immune Globulin (Human) Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Rabies Immune Globulin (Human) Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Rabies Immune Globulin (Human) Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Rabies Immune Globulin (Human) Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Rabies Immune Globulin (Human) Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Rabies Immune Globulin (Human) Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Rabies Immune Globulin (Human) Raw Material
Table 146. Key Manufacturers of Rabies Immune Globulin (Human) Raw Materials
Table 147. Rabies Immune Globulin (Human) Typical Distributors
Table 148. Rabies Immune Globulin (Human) Typical Customers
LIST OF FIGURES
Figure 1. Rabies Immune Globulin (Human) Picture
Figure 2. Global Rabies Immune Globulin (Human) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Rabies Immune Globulin (Human) Consumption Value Market Share by Type in 2022
Figure 4. HyperRAB S/D Examples
Figure 5. KEDRAB Examples
Figure 6. Global Rabies Immune Globulin (Human) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Rabies Immune Globulin (Human) Consumption Value Market Share by Application in 2022
Figure 8. Clinic Examples
Figure 9. Hospital Examples
Figure 10. Global Rabies Immune Globulin (Human) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Rabies Immune Globulin (Human) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Rabies Immune Globulin (Human) Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Rabies Immune Globulin (Human) Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Rabies Immune Globulin (Human) Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Rabies Immune Globulin (Human) Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Rabies Immune Globulin (Human) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Rabies Immune Globulin (Human) Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Rabies Immune Globulin (Human) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Rabies Immune Globulin (Human) Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Rabies Immune Globulin (Human) Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Rabies Immune Globulin (Human) Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Rabies Immune Globulin (Human) Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Rabies Immune Globulin (Human) Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Rabies Immune Globulin (Human) Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Rabies Immune Globulin (Human) Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Rabies Immune Globulin (Human) Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Rabies Immune Globulin (Human) Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Rabies Immune Globulin (Human) Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Rabies Immune Globulin (Human) Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Rabies Immune Globulin (Human) Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Rabies Immune Globulin (Human) Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Rabies Immune Globulin (Human) Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Rabies Immune Globulin (Human) Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Rabies Immune Globulin (Human) Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Rabies Immune Globulin (Human) Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Rabies Immune Globulin (Human) Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Rabies Immune Globulin (Human) Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Rabies Immune Globulin (Human) Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Rabies Immune Globulin (Human) Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Rabies Immune Globulin (Human) Consumption Value Market Share by Region (2018-2029)
Figure 52. China Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Rabies Immune Globulin (Human) Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Rabies Immune Globulin (Human) Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Rabies Immune Globulin (Human) Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Rabies Immune Globulin (Human) Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Rabies Immune Globulin (Human) Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Rabies Immune Globulin (Human) Market Drivers
Figure 73. Rabies Immune Globulin (Human) Market Restraints
Figure 74. Rabies Immune Globulin (Human) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Rabies Immune Globulin (Human) in 2022
Figure 77. Manufacturing Process Analysis of Rabies Immune Globulin (Human)
Figure 78. Rabies Immune Globulin (Human) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Rabies Immune Globulin (Human) Picture
Figure 2. Global Rabies Immune Globulin (Human) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Rabies Immune Globulin (Human) Consumption Value Market Share by Type in 2022
Figure 4. HyperRAB S/D Examples
Figure 5. KEDRAB Examples
Figure 6. Global Rabies Immune Globulin (Human) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Rabies Immune Globulin (Human) Consumption Value Market Share by Application in 2022
Figure 8. Clinic Examples
Figure 9. Hospital Examples
Figure 10. Global Rabies Immune Globulin (Human) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Rabies Immune Globulin (Human) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Rabies Immune Globulin (Human) Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Rabies Immune Globulin (Human) Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Rabies Immune Globulin (Human) Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Rabies Immune Globulin (Human) Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Rabies Immune Globulin (Human) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Rabies Immune Globulin (Human) Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Rabies Immune Globulin (Human) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Rabies Immune Globulin (Human) Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Rabies Immune Globulin (Human) Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Rabies Immune Globulin (Human) Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Rabies Immune Globulin (Human) Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Rabies Immune Globulin (Human) Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Rabies Immune Globulin (Human) Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Rabies Immune Globulin (Human) Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Rabies Immune Globulin (Human) Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Rabies Immune Globulin (Human) Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Rabies Immune Globulin (Human) Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Rabies Immune Globulin (Human) Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Rabies Immune Globulin (Human) Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Rabies Immune Globulin (Human) Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Rabies Immune Globulin (Human) Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Rabies Immune Globulin (Human) Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Rabies Immune Globulin (Human) Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Rabies Immune Globulin (Human) Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Rabies Immune Globulin (Human) Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Rabies Immune Globulin (Human) Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Rabies Immune Globulin (Human) Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Rabies Immune Globulin (Human) Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Rabies Immune Globulin (Human) Consumption Value Market Share by Region (2018-2029)
Figure 52. China Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Rabies Immune Globulin (Human) Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Rabies Immune Globulin (Human) Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Rabies Immune Globulin (Human) Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Rabies Immune Globulin (Human) Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Rabies Immune Globulin (Human) Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Rabies Immune Globulin (Human) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Rabies Immune Globulin (Human) Market Drivers
Figure 73. Rabies Immune Globulin (Human) Market Restraints
Figure 74. Rabies Immune Globulin (Human) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Rabies Immune Globulin (Human) in 2022
Figure 77. Manufacturing Process Analysis of Rabies Immune Globulin (Human)
Figure 78. Rabies Immune Globulin (Human) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
